High Times sits down with Wiz Khalifa to discuss the role of cannabis, his Khalifa Kush strain, fitness transformation, and why he left alcohol behind.

New EEG findings highlighted by DoubleBlind suggest baseline brain rhythms can forecast how intense an ayahuasca experience may feel—useful context for DMV readers.

Psychedelic Alpha flagged a busy “Psychedelics Week” in DC with multiple meetings. Here’s what that activity could signal for policy, access, and the DMV community.

A new UC San Diego analysis of 21,189 adults aged 65+ found 11.4% of past-year cannabis users met DSM-5 criteria for cannabis use disorder, with most cases mild.

Exploring how shared mushroom experiences foster deep human connection amidst evolving drug policy across the DMV region.

Psychedelic Alpha reports that Resilient has resubmitted its MDMA-for-PTSD application two years after a prior rejection. Here’s what to watch, timelines, and DMV impacts.

DoubleBlind Mag reports how Lebanon, the UAE, Jordan, and Egypt are shaping psychedelic-assisted care, from ketamine clinics to policy debates and faith-informed practice.

The psychonaut comic brings a two-part, art-drenched special to life at Meow Wolf Denver. Here’s what to know about TRIPS, why he calls LSD “boring,” and what DMV audiences should watch for.

A power shift at Lykos Therapeutics could revive MDMA-assisted therapy—and Rick Doblin’s influence. Here’s what’s changing, why it matters, and how DMV residents should watch the next moves.

UCSF neuroscientist Robin Carhart-Harris uses brain imaging and clinical trials to explore how psychedelics alter cognition and mood — and what that could mean for patients in the DMV.

Journalist Erica Rex urges caution: psychedelic states can open trauma and power imbalances. Here’s what ethical care, safety, and patient-centered practices should look like in the DMV.

Planning a psychedelic day outside? Here’s a practical, harm‑reduction guide for safe, meaningful nature trips—plus DMV‑specific tips, prep checklists, dosing basics, and what to do if things get hard.

Exploring the science behind messianic experiences on psychedelics, clinical findings, and safe integration for DMV wellness seekers.

A growing movement of fathers is turning to intentional psychedelic journeys and plant medicine to move past burnout and reconnect with family.

Safety, ethics, dosage, vape pens, and the ibogaine combo—what 5‑MeO‑DMT actually demands, and how DMV readers should navigate it without hype.

DoubleBlind Mag spotlights rising 'pill shaming' in psychedelic spaces. Here’s what it means for people on SSRIs, the early research, and how DMV readers can stay safe.

Athletes report flow, less pain, and sharper focus on mushrooms, LSD, and ketamine—but the science is thin. Here’s what research suggests, key risks, and DMV-specific guidance.

From microdosing to mindful presence, a look at how some fathers are weaving psychedelic lessons into parenting—and what DMV families should consider next.

Navigating intense ceremonial connections requires grounded communication, emotional boundaries, and real-world relationship integration.

Definium Therapeutics reports Phase 3 topline success for LSD (DT120) in generalized anxiety disorder, following MDD progress. Here’s the clinical context and what DMV patients should watch.